Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001635088-26-000147

CEO disposed of 156,307 shares (other)

  • CEO gave up 1,600 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gline Matthew CEO 2026-11-10 Other disposition −25,841 $40.43 $1,044,752 16,523,295 D: show line 1 in the form
Gline Matthew CEO 2026-11-10 Other disposition −32,490 $41.13 $1,336,314 16,490,805 D: show line 2 in the form
Gline Matthew CEO 2026-11-11 Other disposition −30,083 $41.63 $1,252,355 16,460,722 D: show line 3 in the form
Gline Matthew CEO 2026-11-11 Other disposition −18,905 $42.01 $794,199 16,441,817 D: show line 4 in the form
Gline Matthew CEO 2026-11-12 Other disposition −41,179 $40.36 $1,661,984 16,400,638 D: show line 5 in the form
Gline Matthew CEO 2026-11-12 Other disposition −7,809 $41.13 $321,184 16,392,829 D: show line 6 in the form
Gline Matthew CEO 2026-11-12 Shares withheld for taxes −1,600 $41.85 $66,960 16,391,229 D: show line 7 in the form
Loading xslF345X06/wk-form4_1794535259.xml…